PrecisionLife

🚀 PrecisionLife wins €2.5m EIC grant to transform endometriosis triage & treatment with unique precision medicine insights 🎉 We’re thrilled to announce that #ProjectTRANSCEND has been awarded a multi-million grant from the European Innovation Council (EIC)! Endometriosis is a complex and debilitating disease affecting 190 million women worldwide, yet diagnosis takes an average of 8–10 years through invasive laparoscopic surgery. This must change. TRANSCEND will develop and clinically validate a rapid, non-invasive precision medicine test using a simple buccal swab. This test will: ✅ Evaluate an individual’s lifetime risk of endometriosis ✅ Uncover disease mechanisms to guide personalized treatments ✅ Enable faster, more accurate triage and specialist referrals ✅ Accelerate repurposed drug trials for better treatment options Our mission is clear: ✔️ Triage & refer faster ✔️ Treat more effectively ✔️ Improve millions of lives Huge thanks to the European Innovation Council and SMEs Executive Agency (EISMEA) for recognizing the urgency of addressing this global health challenge. With this support, we’re working to close the diagnostic gap, improve patient health outcomes, and reduce the cost of care. 🔗 Read more: https://lnkd.in/ez3KHhhA #EndometriosisAwareness #PrecisionMedicine #WomensHealth #EICAccelerator #EUeic #ProjectTRANSCEND

These findings bring us closer to understanding Long COVID and help speed up the development of accurate diagnostics and new treatments for the more than 65 million people around the world experiencing debilitating symptoms. We are grateful to the many partners working together to advance discovery. PrecisionLife researchers used a previous analysis of genetic data from the UK Sano Genetics Long COVID study to identify genes associated with the condition. A collaboration with Metrodora Foundation opened the door for researchers to examine the National Institutes of Health All of US dataset and reproduce these findings. This work continues as Metrodora Institute is now recruiting participants in the US for the MELO Study on ME/CFS and Long COVID, which aims to evaluate biomarkers. Access to the preprint is available in the full press release at the link below. https://lnkd.in/gZQXuNfC

🔬 𝗟𝗮𝗻𝗱𝗺𝗮𝗿𝗸 𝗟𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗦𝘁𝘂𝗱𝘆 𝗖𝗼𝗻𝗳𝗶𝗿𝗺𝘀 𝗞𝗲𝘆 𝗚𝗲𝗻𝗲𝘁𝗶𝗰 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻𝘀 𝗔𝗰𝗿𝗼𝘀𝘀 𝗗𝗶𝘃𝗲𝗿𝘀𝗲 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀: 𝗣𝗮𝘃𝗶𝗻𝗴 𝘁𝗵𝗲 𝗪𝗮𝘆 𝗳𝗼𝗿 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗗𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 & 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 We’re excited to share a major breakthrough in 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝗲𝗮𝗿𝗰𝗵! PrecisionLife, in collaboration with the Metrodora Foundation has successfully 𝗿𝗲𝗽𝗿𝗼𝗱𝘂𝗰𝗲𝗱 𝗸𝗲𝘆 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗿𝗶𝘀𝗸 𝗳𝗮𝗰𝘁𝗼𝗿𝘀 𝗳𝗼𝗿 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗 𝗮𝗰𝗿𝗼𝘀𝘀 𝗱𝗶𝘃𝗲𝗿𝘀𝗲 𝗽𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀, confirming 88% of the genes identified in our previous UK study in an independent US cohort. Why does this matter? ✅ 𝗙𝗶𝗿𝘀𝘁 𝗿𝗲𝗽𝗹𝗶𝗰𝗮𝗯𝗹𝗲 𝗴𝗲𝗻𝗲𝘁𝗶𝗰 𝗳𝗶𝗻𝗱𝗶𝗻𝗴𝘀 𝗳𝗼𝗿 𝗹𝗼𝗻𝗴 𝗖𝗢𝗩𝗜𝗗, reinforcing its biological basis. ✅ 𝗡𝗲𝘄 𝗼𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝗶𝗲𝘀 𝗳𝗼𝗿 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀 to better define and diagnose the condition. ✅ 11 𝗴𝗲𝗻𝗲𝘀 𝘄𝗶𝘁𝗵 𝗱𝗿𝘂𝗴 𝗿𝗲𝗽𝘂𝗿𝗽𝗼𝘀𝗶𝗻𝗴 𝗰𝗮𝗻𝗱𝗶𝗱𝗮𝘁𝗲𝘀 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗲𝗱, supporting their prioritization for clinical trials and accelerating potential new treatments. ✅ 𝗦𝘁𝗿𝗼𝗻𝗴𝗲𝗿 𝘂𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝗳 𝘀𝗵𝗮𝗿𝗲𝗱 𝗯𝗶𝗼𝗹𝗼𝗴𝘆 𝘄𝗶𝘁𝗵 𝗠𝗘/𝗖𝗙𝗦, creating new opportunities for precision medicinein long COVID, ME/CFS and related chronic conditions. This discovery is also advancing the 𝗠𝗘𝗟𝗢 𝗰𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝘀𝘁𝘂𝗱𝘆, which aims to validate biomarkers and repurpose existing drugs to bring real-world benefits to patients. With millions affected and no definitive diagnostic test or treatment yet available, these findings mark a critical step toward precision medicine solutions. 🔍 Read the full press release: https://lnkd.in/ef9ZrMKG A huge thank you to our collaborators at Metrodora Foundation and Metrodora Institute and our data partners at Sano Genetics for their SANO GOLD study data and The National Institutes of Health for their All of Us Study data. Together, we’re unlocking new possibilities for patients with long COVID, ME/CFS, and other complex chronic conditions. #PrecisionMedicine #LongCOVID #MECFS #Diagnostics #DrugDiscovery #HealthcareInnovation #MELOStudy

Following the exciting announcement of 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻𝗟𝗶𝗳𝗲’𝘀 #TRANSCEND project to advance precision medicine solutions for endometriosis (https://lnkd.in/ez3KHhhA), we’re looking forward to continuing the conversation at the Endometriosis Foundation of America Annual Medical Conference 2025 in New York City (Feb 28 – Mar 1). Our Product Strategy Lead, Hannah Bibby, will be attending and would love to connect with researchers, clinicians, and industry leaders to discuss project TRANSCEND and how our 𝘂𝗻𝗶𝗾𝘂𝗲 𝗯𝗶𝗼𝗹𝗼𝗴𝗶𝗰𝗮𝗹 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 are being applied to 𝗯𝗲𝘁𝘁𝗲𝗿 𝗱𝗲𝘁𝗲𝗰𝘁, 𝘁𝗿𝗲𝗮𝘁, 𝗮𝗻𝗱 𝗽𝗿𝗲𝘃𝗲𝗻𝘁 endometriosis and other complex, chronic diseases. If you’re attending and interested in exploring how 𝗽𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗺𝗲𝗱𝗶𝗰𝗶𝗻𝗲 can transform women's health, get in touch! 📍 Where: New York City 📆 When: Feb 28th-Mar 2nd Full details are available on the event website: https://lnkd.in/eG8wavZ #Endometriosis #PrecisionMedicine #WomensHealth #EndoFound

We're honored that our CEO, Steve Gardner, will deliver the keynote lecture at the upcoming ALS/MND Natural History Consortium Annual Meeting in Boston. The consortium, comprising leading academic medical centers from the U.S. and Europe, is dedicated to advancing the understanding of ALS and related motor neuron diseases. 𝗞𝗲𝘆𝗻𝗼𝘁𝗲 𝗟𝗲𝗰𝘁𝘂𝗿𝗲 𝗗𝗲𝘁𝗮𝗶𝗹𝘀 𝗧𝗶𝘁𝗹𝗲: Causal AI-led Precision Medicine, Drug Repurposing, and Rapid Validation Strategies for ALS 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Steve Gardner, CEO, PrecisionLife 𝗗𝗮𝘁𝗲 & 𝗧𝗶𝗺𝗲: Monday, February 24, 11:00 AM - 12:15 PM Steve and PrecisionLife colleagues Bill Keating and Simon Beaulah look forward to contributing to this vital conversation and collaborating with fellow experts to make strides in ALS research. For more information about the meeting, please visit: 🔗 https://lnkd.in/e25GzctT #ALS #MND #ALSResearch #PrecisionMedicine

The Research & Development society is delighted to welcome Steve Gardner, CEO of PrecisionLife Ltd, as a guest writer. Click here to read his analysis on the challenges facing the UK Lifesciences ecosystem and how we should respond to them.

#Precisionmedicine is revolutionizing #healthcare, but which digital technologies are truly making an impact? Join FirstWord's Tina Tan and industry experts Rowan Gardner of PrecisionLife and Mark Van Oene of Pacific Biosciences (PacBio) for this exclusive discussion examining: ✅ Which technologies are driving real-world precision medicine adoption ✅ Where the biggest opportunities lie for pharma and life sciences companies ✅ How you can leverage these innovations for a competitive edge Register today: https://lnkd.in/dw8-GMmS Sponsored by Answers in CME (AiCME) #AI #artificialintelligence #digitalhealth #digitaltechnologies #healthtech #PersonlizedCare #pharmaceuticals #tech #wearables

Introducing Actively Protective Combinatorial Analysis: a Scalable Novel Method for Detecting Variants that Contribute to Reduced Disease Prevalence in High-Risk Individuals. To learn more... ● Read the research paper: https://lnkd.in/euAim6wq ● Contact us: https://lnkd.in/eaTtCDgH ● Meet Steve Gardner at the Hevolution Foundation #GlobalHealthspanSummit2025 #PrecisionMedicine #Longevity #Healthspan #GHS2025

𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝗔𝗰𝘁𝗶𝘃𝗲𝗹𝘆 𝗣𝗿𝗼𝘁𝗲𝗰𝘁𝗶𝘃𝗲 𝗕𝗶𝗼𝗹𝗼𝗴𝘆 𝘁𝗼 𝗜𝗻𝗰𝗿𝗲𝗮𝘀𝗲 𝗛𝗲𝗮𝗹𝘁𝗵𝘀𝗽𝗮𝗻⁣⁣. On the eve of Hevolution Foundation's #GlobalHealthspanSummit, we're thrilled to announce the publication of our latest paper, introducing a new and scalable method for identifying actively protective biology - genetic variants that protect individuals from developing major chronic diseases. 💚 This work paves the way for novel therapeutic strategies and personalized medicine applications that can better predict and prevent the onset and progression of complex diseases that affect billions of patients. 🧬 Representing a significant advancement in genomic research impacting #healthcare, #diagnostics & #drugdevelopment, informing the development of new treatments and prevention strategies. ➡️ Read the full paper in Elsevier Artificial Intelligence in the Life Sciences, here: https://lnkd.in/eJH3D3sb #Genomics #PrecisionMedicine #Bioinformatics #GeneticResearch #HealthcareInnovation #longevity #healthspan #lifespan #research #innovation #healthyaging #GlobalHealthspanSummit2025 #GHS2025

Delighted to see PrecisionLife awesome partner Metrodora Institute discussing how they are seeking solutions for #longcovid and plans for diagnostic studies. excellent job Rohit Gupta and Summer Dashe 👏 👏 👏 👏 👏 #melo